Intervention

Exosomes

Experimental evidence

Exosomes are tiny vesicles cells release to communicate and shuttle cargo between cells. They are being explored as regenerative and anti-ageing therapies, but human longevity evidence is preliminary.

Also known as: exosomes, exosome, extracellular vesicles, EVs, exosome therapy

What exosomes are

Exosomes are nanoscale extracellular vesicles that cells secrete to carry proteins, lipids and RNA to other cells — a key channel of cell-to-cell communication. In therapy they are usually derived from stem cells.

Why they matter for longevity

Stem-cell exosomes carry many of the signalling molecules thought to underlie regenerative effects, which is why they are marketed as a “cell-free” alternative to stem-cell therapy for skin, joints and “anti-ageing”. The idea is to deliver beneficial signals without injecting live cells.

What the evidence shows

Preclinical studies show exosomes can reduce markers of senescence and aid tissue repair, and early-stage human work is emerging. But this is Experimental: products vary enormously in quality and dosing, regulation is inconsistent, and rigorous human outcome trials are largely missing.

What to ask a clinic

Ask about the source and characterisation of the exosomes, regulatory status, what specific outcome is expected, and what controlled evidence supports it. Be cautious of broad “anti-ageing” claims.

Sources & references

  1. ADSC-derived exosomes alleviate senescence and promote regeneration. Science Advances. 2022. doi:10.1126/sciadv.abq2226

Related treatments

Clinics offering this

Related terms

Educational information, not medical advice. Evidence ratings follow our methodology.